Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer.

The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Abstract Text:

    y yamadaY Yamada,s takahashiS Takahashi,t fujimuraT Fujimura,h nishimatsuH Nishimatsu,a ishikawaA Ishikawa,h kumeH Kume,k tomitaK Tomita,t takeuchiT Takeuchi,t kitamuraT Kitamura,y yamadaY Yamada,s takahashiS Takahashi,t fujimuraT Fujimura,h nishimatsuH Nishimatsu,a ishikawaA Ishikawa,h kumeH Kume,k tomitaK Tomita,t takeuchiT Takeuchi,t kitamuraT Kitamura,

    Our study and previous reports suggest that castration results in increased bone turnover and lowered BMD and that these changes might be attenuated by anti-androgens, such as BL and EMP. INTRODUCTION: Recent studies have shown that castration for PC decreases bone mineral density (BMD), while estrogen therapy or bicalutamide (BL) monotherapy maintains BMD. However, the effect of combined androgen blockade (CAB) on bone turnover is not well studied. METHODS: A total of 204 men were evaluated in the study (control group: n = 56, castration group: n = 102, 'CAB with BL' group: n = 22, 'CAB with estramustine phosphate (EMP)' group: n = 24). We measured steroid hormone levels, BMD (measured at one-third distal radius), bone turnover markers (levels of urinary N-telopeptide cross links of type 1 collagen (u-NTx) and deoxypyridinoline (u-DPD), serum concentrations of osteocalcin (OC)) in order to assess differences between groups. RESULTS: The BMD % Z score of the castration group was significantly lower than that of the control group or the 'CAB with EMP' group (90.6% vs. 95.5%, 98.6%; p < 0.042, p < 0.044, respectively). Levels of u-NTx, u-DPD, OC of the castration group were the highest followed by the control group, then the 'CAB with BL' group and the 'CAB with EMP' group. CONCLUSIONS: Our study and previous reports suggests that castration results in increased bone turnover and lowered BMD and that these changes might be attenuated by anti-androgens, such as BL and EMP.

    The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Publishing Authors By Initials

    y yamadaY Yamada,s takahashiS Takahashi,t fujimuraT Fujimura,h nishimatsuH Nishimatsu,a ishikawaA Ishikawa,h kumeH Kume,k tomitaK Tomita,t takeuchiT Takeuchi,t kitamuraT Kitamura,y yamadaY Yamada,s takahashiS Takahashi,t fujimuraT Fujimura,h nishimatsuH Nishimatsu,a ishikawaA Ishikawa,h kumeH Kume,k tomitaK Tomita,t takeuchiT Takeuchi,t kitamuraT Kitamura,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Osteoporosis international : a journal established

    VOLUME: 19

    Page Numbers: 321-7

    Journal Abbreviation:

    ISSN: 0937-941X

    DAY: 29

    MONTH: 09

    YEAR: 2007

    The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9100105

    The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer.

    AFFILIATION: Department of Urology, The Fraternity Memorial Hospital, 2-1-11, Yokoami, Sumida-ku, Tokyo, 130-8587, Japan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Osteoporos Int

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News